Perioperative Atezolizumab Plus Fluorouracil, Leucovorin, Oxaliplatin, and Docetaxel for Resectable Esophagogastric Cancer: Interim Results From the Randomized, Multicenter, Phase II/III ...
Show More 1 Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD Individuals who underwent RRTG as part of a single-institution natural history study of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results